How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses
Abel L. et al, (2024), Health and Quality of Life Outcomes, 22
Physical activity for treatment of irritable bowel syndrome
Nunan D. et al, (2022), Cochrane Database of Systematic Reviews, 2022
PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS
Cai T. et al, (2022), Journal of hypertension, 40, e76 - e77
PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS
Cai T. et al, (2022), JOURNAL OF HYPERTENSION, 40, E76 - E77
PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS
Cai T. et al, (2022), JOURNAL OF HYPERTENSION, 40, E76 - E77
Predicting individual risk of muscle disorders in patients eligible for statin treatment: Derivation and external validation of stratify-statinmd prediction model
Cai T. et al, (2022), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 31, 285 - 285
Predicting individual risk of muscle disorders in patients eligible for statin treatment: derivation and validation of STRATIFY-StatinMD prediction model
Cai T. et al, (2022), JOURNAL OF HUMAN HYPERTENSION, 36, 10 - 10
The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review
Dorward J. et al, (2021), Antiviral Therapy, 25, 365 - 376
Associations between statins and adverse events in primary prevention of cardiovascular disease: a systematic review with meta-analysis
Cai T. et al, (2021), JOURNAL OF HUMAN HYPERTENSION, 35, 11 - 12
The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis
Wu S. et al, (2018), Expert Opinion on Drug Safety, 17, 243 - 249